Three in five women aged 30–49 have never been screened for cervical cancer, according to new WHO estimates . Access to human papillomavirus (HPV) testing is particularly unequal. Only 2% of women in low- and middle-income countries were screened using HPV testing in the preceding five years, compared with 32% in high-income countries.
On World Cervical Cancer Elimination Day, the World Health Organization (WHO) is urging countries to bring screening closer to women who have never been reached and ensure those with screen positive tests receive timely treatment.
“Women who did not have the opportunity to receive HPV vaccination must not also miss out on cervical cancer screening. We have the tools to detect and treat precancerous changes before they develop into cancer. What matters is ensuring that these services reach women who have been left behind, and that a positive screening result leads to timely follow-up and treatment,” said Søren Brostrøm, Director, Noncommunicable Diseases and Mental Health.
Countries putting cervical cancer elimination into action
Across the world, countries are introducing new policies, expanding services and strengthening health systems to accelerate progress towards cervical cancer elimination.
- In Brazil , HPV DNA testing is now available through the public health system in 26 of the country’s 27 federal units, as the country expands access to high-performance cervical cancer screening.
- In Cabo Verde , the Ministry of Health is preparing to introduce organized HPV-based screening on Boa Vista Island, with technical support from WHO in collaboration with the Spanish Agency for International Development Cooperation (AECID).
- In El Salvador , the Ministry of Health is working to expand access to affordable HPV-based screening through new regional agreements supported by PAHO and Unitaid.
- In New Zealand , the government announced its Cervical Cancer Elimination Plan 2026–2040 and will make cervical screening free for all eligible women from March 2027.
- In Sierra Leone , the Ministry of Health is strengthening cervical cancer screening, diagnosis and treatment capacity with HPV tests and new equipment to diagnose and treat precancerous lesions, supported by WHO.
Across countries, cervical cancer elimination is becoming more than a distant ambition, as national commitments take shape through concrete policies, expanded programmes and stronger health services.
Supporting countries to accelerate elimination
To support these country-led efforts, WHO has strengthened its technical guidance and resources for programme implementation.
In 2026, WHO released the WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping , helping countries identify women at greater risk of cervical precancer and guide appropriate follow-up and treatment. Complementary Evidence-informed guidance for the implementation of HPV-based cervical cancer screening programmes offers practical approaches for countries to introduce and scale up HPV-based screening tailored to their national contexts, resources and needs.
To strengthen health workforce capacity, countries are drawing on a comprehensive WHO Academy learning programme on cervical cancer screening, diagnosis and management of precancer. In Liberia , programme materials supported the training of health workers from 12 facilities across Nimba and Grand Bassa counties in July 2026. With WHO support, Zambia plans to pilot the learning programme in December 2026.
Building global momentum for cervical cancer elimination
Under the theme “Together We Can Eliminate Cervical Cancer,” governments, health workers, survivors, civil society and partners are marking World Cervical Cancer Elimination Day through national commitments and community-led action. Among activities taking place around the world are a national commemoration and HPV vaccination campaign in Benin with the support of First Lady Nathalie Villette-Wadagni and partners including Gavi and Unicef; an ambassadorial dialogue convened by Guyana and the Global Center for Health Diplomacy and Inclusion (CeHDI) in Geneva; the launch of a national roadmap towards the 2030 targets in Morocco; a cervical cancer prevention and screening caravan across Senegal; and community advocacy and screening initiatives in Malaysia.
Together, these efforts contribute towards the 2030 targets set out in WHO’s Global Strategy: 90% of girls vaccinated against HPV by age 15, 70% of women screened with a high-performance test by ages 35 and 45, and 90% of women with cervical precancer or invasive cancer receiving appropriate treatment.